unknown
Stage
About
Vaderis is a biotech company developing targeted therapies for Hereditary Hemorrhagic Telangiectasia (HHT) and other rare vascular diseases to address unmet medical needs with no currently approved treatments.
Explore Vaderis's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.